Fractal Analytics Reports Strong Q1 FY27 Growth, Driven by Healthcare and AI Demand — Fractal Analytics Limited

Event summary

Q1 FY27 revenue grew 20% YoY to Rs 912.5 Cr, with net income up 92% YoY to Rs 72.3 Cr.
Healthcare and Life Sciences (HLS) segment led growth at 69% YoY, becoming the second-largest industry in Fractal's portfolio.
Adjusted EBITDA margin expanded by 189 bps YoY to 17%, while gross margin increased by 29 bps to 46%.
Net Revenue Retention stood at 117%, with a Net Promoter Score (NPS) of 77.
TMT segment declined 22% YoY, acting as a drag on overall growth.

The big picture

Fractal Analytics' strong Q1 FY27 performance reflects the growing enterprise demand for AI-driven decision-making, particularly in Healthcare and Financial Services. The company's focus on data sovereignty and multi-model infrastructure positions it well amid evolving regulatory priorities. However, the decline in the TMT segment highlights potential vulnerabilities in a diversified portfolio.

What we're watching

Segment Performance: Whether Fractal can sustain strong growth in Healthcare and Life Sciences while addressing the decline in TMT.
Customer Retention: How the company's Net Revenue Retention of 117% will evolve, given increasing client spending on AI transformation.
AI Investment: The pace at which Fractal's investments in AI R&D and intellectual property will translate into competitive differentiation.